Explore journal overview, editorial leadership, indexing, articles in press, latest published work, and highlights from previous issues.
Monoclonal antibody therapy is a form of immunotherapy that uses monoclonal antibodies (mAb) to bind monospecifically to certain cells or proteins. This treatment will stimulate the patients immune system to attack those cells.
More recently antibodies have been used to bind to molecules involved in T-cell regulation to remove inhibitory pathways that block T-cell responses. This is known as immune checkpoint therapy. It is possible to create a mAb that is specific to almost any extracellular/cell surface target. Research and development is underway to create antibodies for diseases such as rheumatoid arthritis, multiple sclerosis, Alzheimers disease, Ebola and different types of cancers
Edelweiss: Cancer Open Access is an open access journal which aims to publish most complete and genuine source of information in the form of short commentary, mini review, case report, related, but not limited to above areas and making them available freely through online without any subscriptions and restrictions to researches worldwide
Researchers, authors, reviewers, and readers can use this page to find journal resources connected with Monoclonal antibody therapy, including published articles, related academic topics, current issue content, archive material, and manuscript submission information.
Related article links for Monoclonal antibody therapy will appear here as matching content is published in Edelweiss: Cancer Open Access (ISSN: 2689-6737). Readers can also browse the journal archive and current issue for connected research.
